← Back to all trials
Completed
NCT01281137
Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07
Conditions: Breast Cancer
Sex: Female
Ages: 18 Years – 120 Years
Healthy volunteers: No
Enrollment: 104
Sponsor: ETOP IBCSG Partners Foundation
Location: Box Hill Hospital Box Hill Victoria
Summary
RATIONALE: Studying samples of blood in the laboratory from patients receiving treatment for cancer may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.
PURPOSE: This clinical trial is studying changes in estrogen levels and grip strength in postmenopausal women who have received 4 to 6 years of hormone therapy for breast cancer and are currently receiving letrozole on clinical trial IBCSG-35-07.
Eligibility Criteria
DISEASE CHARACTERISTICS:
* Previously diagnosed with breast cancer
* Endocrine-responsive, node-positive, resectable disease
* Disease-free following 4-6 years of prior adjuvant endocrine therapy with selective estrogen-receptor modulators and/or aromatase inhibitors
* Patient must be currently enrolled on clinical trial IBCSG-35-07 as well as the Quality-of-Life substudy
* Hormone receptor status not specified
PATIENT CHARACTERISTICS:
* Postmenopausal
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Source: ClinicalTrials.gov (NCT01281137). StuddyBuddy aggregates publicly available trial information.
